Dimensional Fund Advisors
RCKT icon

Dimensional Fund Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Dimensional Fund Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.03M Sell
288,264
-50,566
-15% -$201K ﹤0.01% 2837
2025
Q4 		$1.19M Sell
338,830
-216,993
-39% -$743K ﹤0.01% 2838
2025
Q3 		$1.81M Sell
555,823
-4,127
-0.7% -$13K ﹤0.01% 2785
2025
Q2 		$1.37M Sell
559,950
-17,538
-3% -$88.8K ﹤0.01% 2838
2025
Q1 		$3.85M Sell
577,488
-183,453
-24% -$1.81M ﹤0.01% 2573
2024
Q4 		$9.56M Sell
760,941
-151,664
-17% -$2.28M ﹤0.01% 2324
2024
Q3 		$16.9M Sell
912,605
-33,570
-4% -$688K ﹤0.01% 2079
2024
Q2 		$20.4M Sell
946,175
-83,613
-8% -$1.92M 0.01% 1943
2024
Q1 		$27.7M Sell
1,029,788
-18,153
-2% -$516K 0.01% 1819
2023
Q4 		$31.4M Sell
1,047,941
-288,731
-22% -$6.37M 0.01% 1742
2023
Q3 		$27.4M Sell
1,336,672
-2,487
-0.2% -$45.2K 0.01% 1746
2023
Q2 		$26.6M Buy
1,339,159
+66,665
+5% +$1.35M 0.01% 1778
2023
Q1 		$21.8M Buy
1,272,494
+144,133
+13% +$2.82M 0.01% 1859
2022
Q4 		$22.1K Buy
1,128,361
+244,792
+28% +$4.51M 0.01% 1824
2022
Q3 		$14.1M Buy
883,569
+446,574
+102% +$6.97M 0.01% 2009
2022
Q2 		$6.01M Buy
436,995
+21,730
+5% +$259K ﹤0.01% 2399
2022
Q1 		$6.59M Buy
415,265
+28,826
+7% +$498K ﹤0.01% 2458
2021
Q4 		$8.44M Buy
386,439
+11,983
+3% +$327K ﹤0.01% 2371
2021
Q3 		$11.2M Sell
374,456
-122,854
-25% -$4.47M ﹤0.01% 2285
2021
Q2 		$22M Buy
497,310
+189,020
+61% +$8.21M 0.01% 2009
2021
Q1 		$13.7M Sell
308,290
-27,716
-8% -$1.52M ﹤0.01% 2201
2020
Q4 		$18.4M Sell
336,006
-7,006
-2% -$255K 0.01% 2015
2020
Q3 		$7.84M Buy
343,012
+3,104
+0.9% +$76.5K ﹤0.01% 2302
2020
Q2 		$7.12M Buy
339,908
+64,422
+23% +$1.16M ﹤0.01% 2339
2020
Q1 		$3.84M Buy
275,486
+19,578
+8% +$388K ﹤0.01% 2509
2019
Q4 		$5.83M Buy
255,908
+115,850
+83% +$1.93M ﹤0.01% 2557
2019
Q3 		$1.63M Buy
140,058
+119,334
+576% +$1.48M ﹤0.01% 2908
2019
Q2 		$311K Buy
20,724
+8,612
+71% +$150K ﹤0.01% 3261
2019
Q1 		$212K Hold
12,112
– – ﹤0.01% 3298
2018
Q4 		$179K Buy
+12,112
New +$201K ﹤0.01% 3302
2017
Q3 		– Sell
-8,970
Closed -$68K – 3346
2017
Q2 		$68K Buy
8,970
+2,092
+30% +$15.6K ﹤0.01% 3275
2017
Q1 		$55K Sell
6,878
-772
-10% -$5.19K ﹤0.01% 3274
2016
Q4 		$187K Hold
7,650
– – ﹤0.01% 3211
2016
Q3 		$290K Buy
+7,650
New +$241K ﹤0.01% 3146

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors's RCKT Position: Q1 2026 in Review

Dimensional Fund Advisors reduced its Rocket Pharmaceuticals (RCKT) stake by 15% in Q1 2026, selling an estimated $201K and leaving 288,264 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2837.

Dimensional Fund Advisors first reported a position in RCKT in Q3 2016 and has held it in 34 quarters since. The position peaked at $31.4M in Q4 2023. 198 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Dimensional Fund Advisors held 288,264 shares of Rocket Pharmaceuticals worth $1.03M as of Q1 2026.
  • Dimensional Fund Advisors sold 50,566 Rocket Pharmaceuticals shares in Q1 2026, an estimated $201K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2837 holding.
  • Dimensional Fund Advisors first reported a position in Rocket Pharmaceuticals in Q3 2016 and has held it in 34 quarters since.
  • Dimensional Fund Advisors's Rocket Pharmaceuticals position peaked at $31.4M in Q4 2023.
  • 198 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.